trending Market Intelligence /marketintelligence/en/news-insights/trending/8s41s3isazph8ncthj-vtw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Siemens Healthineers posts 7% YOY drop in fiscal Q3 income

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Siemens Healthineers posts 7% YOY drop in fiscal Q3 income

Siemens Healthineers AG's adjusted net income for its fiscal third quarter ended June 30 fell 7% year over year to €334 million, amid currency headwinds.

The German maker of imaging and diagnostic devices was taken public by industrial conglomerate Siemens Aktiengesellschaft in a 4.2 billion IPO in March.

The adjusted net income for the April-June period includes lower financing interests due to implementation of a post-IPO capital structure, and is partly offset by higher income taxes, the company said in its earnings release.

Meanwhile, the medical device maker's net income attributable to shareholders fell to 285 million, or 29 euro cents per share, from €320 million, or 32 cents per share, a year earlier.

Revenue for the fiscal third quarter edged lower to €3.30 billion from €3.31 billion in the year-ago period, on an actual basis, mainly due to exchange rate fluctuations.

However, on a comparable basis, revenue increased 5% year over year on the back of higher sales from the imaging business which sells x-ray and and MRI machines. The comparable basis excludes exchange rate and portfolio effects, the company said.

For the fiscal year ending Sept. 30, Siemens Healthineers re-affirmed its previous forecast of an year-over-year comparable revenue growth of 3% to 4%.

"Despite increasingly negative currency effects and investments in the future of the laboratory diagnostics business, we confirm our guidance for the current fiscal year," CEO Bernd Montag said in the release.